Nov 6, 2025 · Cosentyx (secukinumab) is an IL-17A blocker used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and other autoimmune conditions. Includes Cosentyx …

Oct 5, 2025 · Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease in certain patients. Includes side effects, dose, uses, …

Jul 24, 2025 · Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Includes side effects, dose, interactions and indications.

Dec 28, 2024 · Biologics are administered via subcutaneous injection or intravenous infusion and are reserved for moderate to severe cases of psoriasis. Other biologic drugs include tumor …

Nov 11, 2025 · Skyrizi (risankizumab) is an injection used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Includes indications, doses, interactions, side …

Dec 12, 2024 · Tildrakizumab injection is used for moderate-to-severe plaque psoriasis to reduce plaques, scales, and redness. Includes tildrakizumab side effects, dose, uses, and more

Aug 26, 2025 · Stelara (ustekinumab) injection is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Stelara is an interleukin inhibitor that blocks IL-12 and …

Dec 12, 2024 · Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques, scales, and redness. Includes Ilumya side effects, dose, uses and more

Jan 14, 2024 · Compare risks and benefits of common medications used for Psoriasis. Find the most popular drugs, view ratings and user reviews.

Jun 3, 2025 · Yesintek is an interchangeable biosimilar to Stelara used to treat plaque psoriasis, active psoriatic arthritis, or moderately to severely active Crohn's disease or ulcerative colitis in …